Sustained peptide-release formulation

Details Sustained peptide-release formulation Sustained peptide-release formulation

2007-12-18

2007-12-18

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S015800

Reexamination Certificate

active

10808504

ABSTRACT:
A pharmaceutical and/or veterinary formulation for sustained release of a peptide agonist or analogue, comprising about 2-15% (w/w) of at least one peptide agonist or analogue other than deslorelin (on an active basis), about 0.5-3.5% (w/w) lecithin and the balance sterin. The formulation preferably comprises a GnRH agonist or analogue and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial, particularly prostate cancer, ovarian and breast cancer, and benign prostatic hyperplasia in dogs.

REFERENCES:
patent: 5039660 (1991-08-01), Leonard
patent: 5256649 (1993-10-01), Le Fur et al.
patent: 5340585 (1994-08-01), Pike
patent: 5372996 (1994-12-01), Labrie
patent: 5573781 (1996-11-01), Brown et al.
patent: 5925619 (1999-07-01), Walsh
patent: 6337318 (2002-01-01), Trigg et al.
patent: A-41059/85 (1985-10-01), None
patent: 0 158 277 (1985-10-01), None
patent: 0 254 693 (1988-01-01), None
patent: 0 645 136 (1995-03-01), None
patent: 2 052 258 (1981-01-01), None
patent: 62-192327 (1987-08-01), None
patent: 86/04503 (1986-08-01), None
patent: 92/18107 (1992-10-01), None
patent: WO 93/07833 (1993-04-01), None
patent: 92/15722 (1993-08-01), None
patent: 96/34012 (1996-10-01), None
patent: WO 97/00693 (1997-01-01), None
Liu et al; “Effects of Pituitary-Testicular Axis Suppressionin Uteroand during . . . ”,Journal of Endocrinology and Metabolism, vol. 73, No. 5, pp. 1038-1043 (1991).
Hawley's Condensed Chemical Dictionary, 13thed., John Wiley & Sons, Inc., pp. 666, 1046 and 1047 (1997).

Affiliated with

Also associated with

Rating

Sustained peptide-release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained peptide-release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained peptide-release formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3844455